Interleukin-31 Receptor alpha Antagonists [MoA] - N0000194122

Pharmacologic Code	N0000194122
Pharmacologic Name	Interleukin-31 Receptor alpha Antagonists
Pharmacologic Uses	interleukin-31 receptor alpha antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Interleukin-31 Receptor alpha Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0299-6220	Nemluvio	Non-Proprietary Name: Nemolizumab-ilto	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Galderma Laboratories, L.p.	ACTIVE